Using MOVE! With Seriously Mentally Ill Veterans
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- VA Maryland Health Care System, Baltimore
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- DSM- IV diagnosis of schizophrenia spectrum disorders OR a DSM-IV diagnosis of other severe mental disorder including bipolar disorder, major depression, or severe anxiety disorder;
- Age between 18-64;
- No psychiatric hospitalization in 3-month period prior to enrollment;
- Community residency within 30 miles of either VA facility;
- A BMI of 25 or higher;
- Voluntary consent after receiving full information about the study;
- English speaking;
- Veteran of the armed forces
Exclusion Criteria:
- Active cancer other than non-melanoma skin cancer
- end stage chronic obstructive pulmonary disease
- end stage congestive heart failure
- end-stage neurological disorder
- problematic substance abuse as defined by provider
- end stage renal disease
- moderate to severe cognitive impairment (dementia, post-stroke)
- HIV positive with a CD4 count less than or equal to 350 within the last 6 months
- anorexia
- current pregnancy, currently nursing or planning to become pregnant in the next 6 months
- those living in long-term care facilities
- use in past 3 months of prescription pharmacological agents for weight loss
- no chart documented VA delivered medical primary care or general somatic care visit within the last 18 months
- most recent chart documented hematocrit level obtained within last six months is at or below 30%
- most recent chart documented creatinine level obtained within the last six months that is at or above 2.5
- most recent chart documented liver function tests obtained within the last six months exceeds twice the normal value for ALT, AST test in the Baltimore VA laboratory
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Arm 1
The intervention group completes approximately 8 individual level sessions with a MOVE specialist as well as approximately 8 group level intervention sessions.
|
group based psychoeducation, motivation and support
|
|
No Intervention: Arm 2
The control group offers basic information about diet and exercise every month for six months.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight Measurement
Time Frame: baseline and six months
|
Weight taken at the baseline assessment and again at the 6 month assessment
|
baseline and six months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Impact of Weight on Quality of Life Survey (IWQOL)
Time Frame: baseline and six months
|
Raw scores for this measure were converted to a range from 0 to 100, with higher scores indicating lower impact of weight on quality of life.
|
baseline and six months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Richard W Goldberg, PhD, VA Maryland Health Care System, Baltimore
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- D4219-R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.